Bryce D. Carmine retired as an executive vice president at Eli Lilly & Co. and president of Lilly Bio-Medicines in 2011. Previously, he was executive Vice President, Global Marketing and Sales, with the company. Carmine joined Lilly in 1975 in New Zealand and subsequently held several marketing and management positions in New Zealand and in the U.S. in the early ’80s before becoming general manager of a joint venture pharmaceutical company in South Korea.
He subsequently managed the Lilly operations in Australia/NZ before becoming president of Eli Lilly Japan from 1995 to June 1999 when he was named President, Global Product Development. He had several leadership roles throughout his career in industry associations culminating in the chairman of ISEC and a board member of the European Association, EFPIA. at the time of his retirement.
Carmine received his Bachelor of Science in biochemistry from Massey University (NZ).
Retired Executive Vice President
Eli Lilly & Co.